# Study in Adult Patients With Moderate to Severe Asthma

> **NCT04886999** · PHASE3 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 78 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Beclomethasone dipropionate 100 µg / Formoterol fumarate 6 µg (Inhaler A)
- **DRUG:** Beclomethasone dipropionate 100 µg / Formoterol fumarate 6 µg (Inhaler B)

## Key facts

- **NCT ID:** NCT04886999
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-24
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886999, "Study in Adult Patients With Moderate to Severe Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04886999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*